These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

816 related items for PubMed ID: 18602514

  • 1. Bleeding risk and outcomes of Bivalirudin versus Glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated Heparin in patients having percutaneous coronary intervention for either stable or unstable angina pectoris.
    Steinberg DH, Shah P, Kinnaird T, Pinto Slottow TL, Roy PK, Okabe T, Bonello L, de Labriolle A, Smith KA, Torguson R, Xue Z, Suddath WO, Kent KM, Satler LF, Pichard AD, Lindsay J, Waksman R.
    Am J Cardiol; 2008 Jul 15; 102(2):160-4. PubMed ID: 18602514
    [Abstract] [Full Text] [Related]

  • 2. Bleeding risk comparing targeted low-dose heparin with bivalirudin in patients undergoing percutaneous coronary intervention: results from a propensity score-matched analysis of the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry.
    Bangalore S, Cohen DJ, Kleiman NS, Regev-Beinart T, Rao SV, Pencina MJ, Mauri L, EVENT Registry Investigators, Boston, MA.
    Circ Cardiovasc Interv; 2011 Oct 01; 4(5):463-73. PubMed ID: 21972401
    [Abstract] [Full Text] [Related]

  • 3. Safety and efficacy of a prolonged bivalirudin infusion after urgent and complex percutaneous coronary interventions: a descriptive study.
    Cortese B, Micheli A, Picchi A, Bandinelli L, Brizi MG, Severi S, Limbruno U.
    Coron Artery Dis; 2009 Aug 01; 20(5):348-53. PubMed ID: 19543084
    [Abstract] [Full Text] [Related]

  • 4. Comparison of patient outcomes with bivalirudin versus unfractionated heparin in percutaneous coronary intervention.
    Watson K, Seybert AL, Saul MI, Lee JS, Kane-Gill SL.
    Pharmacotherapy; 2007 May 01; 27(5):647-56. PubMed ID: 17461699
    [Abstract] [Full Text] [Related]

  • 5. Economic impact of switching to bivalirudin for a primary percutaneous coronary intervention in a US hospital.
    Olchanski N, Slawsky KA, Plent S, Kado C, Cyr PL.
    Hosp Pract (1995); 2010 Nov 01; 38(4):138-46. PubMed ID: 21068538
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of bivalirudin in patients with diabetes mellitus undergoing percutaneous coronary intervention in current clinical practice.
    Kim LK, Wong SC, Minutello RM, Bergman G, Feldman DN.
    J Invasive Cardiol; 2010 Mar 01; 22(3):94-100. PubMed ID: 20197573
    [Abstract] [Full Text] [Related]

  • 7. Safety and efficacy of bivalirudin for percutaneous coronary intervention with rotational atherectomy.
    Delhaye C, Wakabayashi K, Maluenda G, Ben-Dor I, Torguson R, Xue Z, Suddath WO, Satler LF, Pichard AD, Kent KM, Lindsay J, Waksman R.
    J Interv Cardiol; 2010 Jun 01; 23(3):223-9. PubMed ID: 20636842
    [Abstract] [Full Text] [Related]

  • 8. Bivalirudin during primary PCI in acute myocardial infarction.
    Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ, Pocock SJ, Dangas G, Wong SC, Kirtane AJ, Parise H, Mehran R, HORIZONS-AMI Trial Investigators.
    N Engl J Med; 2008 May 22; 358(21):2218-30. PubMed ID: 18499566
    [Abstract] [Full Text] [Related]

  • 9. Comparison of safety and efficacy of bivalirudin versus unfractionated heparin in high-risk patients undergoing percutaneous coronary intervention (from the Anti-Thrombotic Strategy for Reduction of Myocardial Damage During Angioplasty-Bivalirudin vs Heparin study).
    Patti G, Pasceri V, D'Antonio L, D'Ambrosio A, Macrì M, Dicuonzo G, Colonna G, Montinaro A, Di Sciascio G.
    Am J Cardiol; 2012 Aug 15; 110(4):478-84. PubMed ID: 22583760
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of heparin and bivalirudin in patients undergoing percutaneous coronary intervention without use of glycoprotein IIb/IIIa inhibitors.
    Abtahian F, Waldo S, Jang IK.
    Catheter Cardiovasc Interv; 2015 Sep 15; 86(3):390-6. PubMed ID: 25753749
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of bivalirudin in patients receiving clopidogrel therapy after diagnostic angiography for percutaneous coronary intervention in acute coronary syndromes.
    Feldman DN, Minutello RM, Bergman G, Moussa I, Wong SC.
    Catheter Cardiovasc Interv; 2010 Oct 01; 76(4):513-24. PubMed ID: 20882655
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Head-to-head comparison of bivalirudin versus heparin without glycoprotein IIb/IIIa inhibitors in patients with acute myocardial infarction undergoing primary angioplasty.
    Bonello L, de Labriolle A, Roy P, Steinberg DH, Pinto Slottow TL, Xue Z, Kaneshige K, Torguson R, Suddath WO, Satler LF, Kent KM, Pichard AD, Waksman R.
    Cardiovasc Revasc Med; 2009 Oct 01; 10(3):156-61. PubMed ID: 19595396
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Bivalirudin in PCI: an overview of the REPLACE-2 trial.
    Maroo A, Lincoff AM.
    Semin Thromb Hemost; 2004 Jun 01; 30(3):329-36. PubMed ID: 15282655
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Use and Effectiveness of Bivalirudin Versus Unfractionated Heparin for Percutaneous Coronary Intervention Among Patients With ST-Segment Elevation Myocardial Infarction in the United States.
    Secemsky EA, Kirtane A, Bangalore S, Jovin IS, Shah RM, Ferro EG, Wimmer NJ, Roe M, Dai D, Mauri L, Yeh RW.
    JACC Cardiovasc Interv; 2016 Dec 12; 9(23):2376-2386. PubMed ID: 27838271
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.